Jeremy Rassen, Sc.D.

Dr. Rassen is an epidemiologist and computer scientist with more than 25 years of experience in how causal inference and artificial intelligence (AI) can drive understanding of the safety, effectiveness and value of medical treatments.

He co-founded Aetion to pursue a vision of technology providing the speed, scale and rigor required to answer high-stakes questions in healthcare. Dr. Rassen has overseen Aetion’s work with 18 of the 20 top global pharma companies, as well as many other customers around healthcare.

During the COVID-19 pandemic, he initiated Aetion’s research collaborations with the U.S. Food and Drug Administration (FDA) and was a leading voice on how RWE could be applied to decisions around COVID-19 and other critical decisions in healthcare.

Prior to Aetion, Dr. Rassen was an assistant professor of medicine at Harvard Medical School, where he developed methods to improve the quality and validity of RWD studies. He started his career in Silicon Valley, where he was the first employee at E.piphany to join the company’s founders to build a novel, data-driven customer relationship management (CRM) platform and sell it to Fortune 50 companies. Dr. Rassen received a Bachelor of Arts in Computer Science from Harvard University and a Doctor of Science in Epidemiology from the Harvard T.H. Chan School of Public Health. He is a fellow and board member of the International Society of Pharmacoepidemiology.